304 related articles for article (PubMed ID: 2881448)
21. Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease.
Yoshimura M
Eur Neurol; 1988; 28 Suppl 1():29-35. PubMed ID: 3378559
[TBL] [Abstract][Full Text] [Related]
22. Potential nondopaminergic drugs for Parkinson's disease.
Silverdale MA; Fox SH; Crossman AR; Brotchie JM
Adv Neurol; 2003; 91():273-91. PubMed ID: 12442686
[No Abstract] [Full Text] [Related]
23. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease.
Rinne JO; Paljärvi L; Rinne UK
J Neurol Sci; 1987 Jun; 79(1-2):67-76. PubMed ID: 3612173
[TBL] [Abstract][Full Text] [Related]
24. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease.
Beal MF; MacGarvey U; Swartz KJ
Ann Neurol; 1990 Aug; 28(2):157-61. PubMed ID: 1699471
[TBL] [Abstract][Full Text] [Related]
25. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
Wilcock GK; Esiri MM; Bowen DM; Hughes AO
J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):842-9. PubMed ID: 3404192
[TBL] [Abstract][Full Text] [Related]
26. The role of the nucleus basalis of Meynert in dementia: review and reconsideration.
Cummings JL; Benson DF
Alzheimer Dis Assoc Disord; 1987; 1(3):128-55. PubMed ID: 3331115
[TBL] [Abstract][Full Text] [Related]
27. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
[TBL] [Abstract][Full Text] [Related]
28. Overview of morphological changes in Parkinson's disease.
Jellinger K
Adv Neurol; 1987; 45():1-18. PubMed ID: 3825687
[No Abstract] [Full Text] [Related]
29. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.
Candy JM; Perry RH; Perry EK; Irving D; Blessed G; Fairbairn AF; Tomlinson BE
J Neurol Sci; 1983 May; 59(2):277-89. PubMed ID: 6854353
[TBL] [Abstract][Full Text] [Related]
30. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.
Dexter DT; Sian J; Jenner P; Marsden CD
Adv Neurol; 1993; 60():273-81. PubMed ID: 8420143
[No Abstract] [Full Text] [Related]
31. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
Bird TD; Stranahan S; Sumi SM; Raskind M
Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
[TBL] [Abstract][Full Text] [Related]
32. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
[TBL] [Abstract][Full Text] [Related]
33. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
Wichmann T; DeLong MR
Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
[No Abstract] [Full Text] [Related]
34. [Loss of neurons in the nucleus basalis of Meynert in Pick disease].
Sasaki S; Aikawa T; Minagawa M; Kobayashi I; Maruyama S
Rinsho Shinkeigaku; 1985 Jul; 25(7):812-7. PubMed ID: 4075645
[No Abstract] [Full Text] [Related]
35. A pathological study of the association between Lewy body disease and Alzheimer's disease.
Gibb WR; Mann DM; Mountjoy CQ; Lees AJ
Adv Neurol; 1990; 53():55-9. PubMed ID: 2173375
[No Abstract] [Full Text] [Related]
36. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease.
Arendt T; Bigl V; Tennstedt A; Arendt A
Neuroscience; 1985 Jan; 14(1):1-14. PubMed ID: 3974875
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer plaques and cortical cholinergic innervation.
Mesulam MM
Neuroscience; 1986; 17(1):275-6. PubMed ID: 3960313
[No Abstract] [Full Text] [Related]
38. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.
Rinne JO; Rummukainen J; Paljärvi L; Säkö E; Mölsä P; Rinne UK
Prog Clin Biol Res; 1989; 317():325-32. PubMed ID: 2602422
[TBL] [Abstract][Full Text] [Related]
39. Abnormalities of the nucleus basalis in Down's syndrome.
Casanova MF; Walker LC; Whitehouse PJ; Price DL
Ann Neurol; 1985 Sep; 18(3):310-3. PubMed ID: 2932050
[TBL] [Abstract][Full Text] [Related]
40. Pathologic correlates of dementia in Parkinson's disease.
Chui HC; Mortimer JA; Slager U; Zarow C; Bondareff W; Webster DD
Arch Neurol; 1986 Oct; 43(10):991-5. PubMed ID: 3753274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
